Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CZBW | ISIN: US44486Q1031 | Ticker-Symbol:
NASDAQ
17.05.24
22:00 Uhr
6,330 US-Dollar
-0,090
-1,40 %
1-Jahres-Chart
HUMACYTE INC Chart 1 Jahr
5-Tage-Chart
HUMACYTE INC 5-Tage-Chart

Aktuelle News zur HUMACYTE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoHedge Fund and Insider Trading News: Michael Burry, Leon Cooperman, Ray Dalio, Stanley Druckenmiller, Millennium Management, Paulson & Co, Rokos Capital Management, Humacyte Inc (HUMA), GeneDx Holdings Corp. (WGS), and More2
DiHumacyte extends gains as FDA reviews blood vessel product3
MoHumacyte, Inc. - 10-Q, Quarterly Report1
MoEarnings call: Humacyte anticipates strong market entry post-FDA review9
10.05.Peering Into Humacyte's Recent Short Interest3
10.05.Humacyte Inc reports results for the quarter ended in March - Earnings Summary-
10.05.Humacyte GAAP EPS of -$0.29 misses by $0.062
10.05.Humacyte, Inc. - 8-K, Current Report2
09.05.Humacyte Q1 2024 Earnings Preview1
19.04.Here's why the Humacyte (HUMA) stock price is pumping7
28.03.Humacyte, Inc. - S-8, Securities to be offered to employees in employee benefit plans3
28.03.Humacyte, Inc. - 10-K, Annual Report4
26.03.Humacyte, Inc: Humacyte to Host Virtual KOL Event "Hemodialysis Access: A Crossroads of Care," on March 28, 20243
23.03.Humacyte, Inc. (HUMA) Q4 2023 Earnings Call Transcript3
22.03.Earnings call: Humacyte reports Q4 results, FDA priority review for HAV1
22.03.Humacyte Inc reports results for the quarter ended in December - Earnings Summary3
22.03.Humacyte GAAP EPS of -$0.24 in-line1
22.03.Humacyte, Inc. - 8-K, Current Report1
22.03.Humacyte, Inc: Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update152-Biologics License Application (BLA) for HAV Accepted by FDA on February 8, 2024- -BLA Granted Priority Review for Vascular Trauma Indication; PDUFA date set for August 10, 2024- -Raised approximately...
► Artikel lesen
21.03.Humacyte Q4 2023 Earnings Preview1
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1